EUVIMEDEUVIMED entdecken
ValidierungsstudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire

Elisa Franceschi, Alessandro De Angelis iD, Andrea Gramegna, Ilaria Baiardini, Edoardo Simonetta, Mattia Nigro iD, Anna Stainer, Veronica Polelli, Francesco Bini, Fulvio Braido, Francesco Blasi, Stefano Aliberti

Therapeutic Advances in Respiratory Disease · 2026-08 · 20

DOI: 10.1177/17534666261471303 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 11.08.2026. Verfasst von Elisa Franceschi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Unit, ASST Rhodense Garbagnate Milanese Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Bronchiectasis, Quality of Life, Patient Reported Outcome Measures. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient-reported outcome measures are essential tools for assessing disease burden in bronchiectasis. The Quality of Life–Bronchiectasis questionnaire (QoL-B) is widely used in clinical research, but a validated Italian version has not been available.

Objectives

To perform a cross-cultural validation of the Italian QoL-B in a real-world cohort of patients with bronchiectasis.

Design

Prospective observational cross-cultural validation study.

Methods

Adult patients with bronchiectasis attending a tertiary referral clinic were prospectively enrolled. The Italian QoL-B was administered at baseline (T0) and after 15 days (T1) in clinically stable patients to assess internal consistency and test–retest reliability. Construct validity was evaluated through predefined hypotheses by comparing QoL-B domain scores across clinically relevant subgroups, including exacerbation frequency, dyspnea severity, lung function impairment, and Bronchiectasis Severity Index (BSI) class. Exploratory analyses assessed score variation during exacerbations.

Results

A total of 108 patients were included (median age 64.5 years; 75.9% female). Internal consistency was good across domains (Cronbach’s α 0.78–0.89), and test–retest reliability showed stable scores between T0 and T1 with high intraclass correlation coefficients. Construct validity was supported by significant discrimination across disease-burden groups: patients with frequent exacerbations, severe BSI class, or greater dyspnea reported consistently lower scores, particularly in physical functioning and respiratory symptoms domains. The Emotional Functioning domain showed weaker associations with disease severity indicators and was primarily related to mood disorders. QoL-B scores were substantially lower during exacerbations.

Conclusion

The Italian QoL-B demonstrates good reliability and construct validity and provides a robust instrument for assessing quality of life in Italian-speaking patients with bronchiectasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchiectasisQuality of LifePatient Reported Outcome MeasuresHumansFemaleMiddle AgedItalyProspective StudiesReproducibility of ResultsAgedMaleSeverity of Illness IndexSurveys and QuestionnairesPredictive Value of TestsCross-Cultural Comparison

Stichwörter der Autor:innen

bronchiectasispatient reported outcome measuresquality of life

Autor:innen und Institutionen

  • Pulmonology Unit, ASST Rhodense Garbagnate Milanese Hospital, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Milan, Italy.
  • Respiratory and Cystic Fibrosis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Department of Pathophysiology and Transplantation, University of Milan, Italy.
  • Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy.

ORCID-Profile: Alessandro De Angelis, Mattia Nigro

Zitieren

APA

Franceschi, E., De Angelis, A., Gramegna, A., Baiardini, I., Simonetta, E., Nigro, M., Stainer, A., Polelli, V., Bini, F., Braido, F., Blasi, F., & Aliberti, S. (2026). Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261471303

Vancouver

Franceschi E, De Angelis A, Gramegna A, Baiardini I, Simonetta E, Nigro M, et al. Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261471303

BibTeX
@article{Franceschi2026,
  author = {Franceschi, Elisa and De Angelis, Alessandro and Gramegna, Andrea and Baiardini, Ilaria and Simonetta, Edoardo and Nigro, Mattia and Stainer, Anna and Polelli, Veronica and Bini, Francesco and Braido, Fulvio and Blasi, Francesco and Aliberti, Stefano},
  title = {Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261471303}
}
Kostenlos starten →